Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,084 DKK | -1.98% | +3.73% | -3.29% |
Mar. 18 | Genmab Completes Share Buyback Program | MT |
Mar. 15 | Genmab to Repurchase Up to $511 Million Shares | MT |
Sales 2024 * | 19.62B 2.84B | Sales 2025 * | 23.49B 3.4B | Capitalization | 136B 19.67B |
---|---|---|---|---|---|
Net income 2024 * | 5.18B 751M | Net income 2025 * | 6.87B 995M | EV / Sales 2024 * | 5.42 x |
Net cash position 2024 * | 29.58B 4.28B | Net cash position 2025 * | 34.56B 5B | EV / Sales 2025 * | 4.31 x |
P/E ratio 2024 * |
26.1
x | P/E ratio 2025 * |
20
x | Employees | 2,204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.86% |
Latest transcript on Genmab A/S
1 day | -1.98% | ||
1 week | +3.73% | ||
Current month | +7.98% | ||
1 month | +4.80% | ||
3 months | -2.53% | ||
6 months | -17.17% | ||
Current year | -3.29% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Anders Pedersen
BRD | Director/Board Member | 73 | 03-10-31 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 196 M€ | +12.16% | ||
1.28% | 49 M€ | +7.05% | ||
1.01% | 80 M€ | +3.25% | ||
0.75% | 18 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 2,084 | -1.98% | 88,114 |
24-03-26 | 2,126 | +2.95% | 125,434 |
24-03-25 | 2,065 | -0.82% | 79,817 |
24-03-22 | 2,082 | +2.41% | 105,625 |
24-03-21 | 2,033 | +1.19% | 119,830 |
Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.29% | 19.71B | |
+2.83% | 108B | |
+9.51% | 104B | |
+6.58% | 23.66B | |
-11.88% | 22.1B | |
-35.36% | 18.2B | |
-13.48% | 16.19B | |
+4.39% | 13.72B | |
+33.65% | 12.22B | |
-6.55% | 10.36B |